Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.AuthorsFinn, R. S.; Ahn, D. H.; Javle, M. M.; Tan, B. R.; Weekes, C. D.; Bendell, J. C.; Patnaik, A.; Khan, G. N.; Laheru, D.; Chavira, R.; Christy-Bittel, J.; Barrett, E.; Sawyer, M. B.; Bekaii-Saab, Tanios S.PublicationInvestigational New Drugs, 2018, Vol 36, Issue 6, p1037ISSN0167-6997Publication typeArticleDOI10.1007/s10637-018-0600-2